BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27920753)

  • 1. Neuroproteomics and Systems Biology Approach to Identify Temporal Biomarker Changes Post Experimental Traumatic Brain Injury in Rats.
    Kobeissy FH; Guingab-Cagmat JD; Zhang Z; Moghieb A; Glushakova OY; Mondello S; Boutté AM; Anagli J; Rubenstein R; Bahmad H; Wagner AK; Hayes RL; Wang KK
    Front Neurol; 2016; 7():198. PubMed ID: 27920753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment.
    Abou-Abbass H; Bahmad H; Abou-El-Hassan H; Zhu R; Zhou S; Dong X; Hamade E; Mallah K; Zebian A; Ramadan N; Mondello S; Fares J; Comair Y; Atweh S; Darwish H; Zibara K; Mechref Y; Kobeissy F
    Electrophoresis; 2016 Jun; 37(11):1562-76. PubMed ID: 27249377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel differential neuroproteomics analysis of traumatic brain injury in rats.
    Kobeissy FH; Ottens AK; Zhang Z; Liu MC; Denslow ND; Dave JR; Tortella FC; Hayes RL; Wang KK
    Mol Cell Proteomics; 2006 Oct; 5(10):1887-98. PubMed ID: 16801361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping Spatiotemporal Microproteomics Landscape in Experimental Model of Traumatic Brain Injury Unveils a link to Parkinson's Disease.
    Mallah K; Quanico J; Raffo-Romero A; Cardon T; Aboulouard S; Devos D; Kobeissy F; Zibara K; Salzet M; Fournier I
    Mol Cell Proteomics; 2019 Aug; 18(8):1669-1682. PubMed ID: 31204315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Proteomics Reveals the Dynamic Pathophysiology Across Different Stages in a Rat Model of Severe Traumatic Brain Injury.
    Luo W; Yang Z; Zhang W; Zhou D; Guo X; Wang S; He F; Wang Y
    Front Mol Neurosci; 2021; 14():785938. PubMed ID: 35145378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice.
    Thompson SN; Gibson TR; Thompson BM; Deng Y; Hall ED
    Exp Neurol; 2006 Sep; 201(1):253-65. PubMed ID: 16814284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leveraging biomarker platforms and systems biology for rehabilomics and biologics effectiveness research.
    Kobeissy FH; Guingab-Cagmat JD; Razafsha M; O'Steen L; Zhang Z; Hayes RL; Chiu WT; Wang KK
    PM R; 2011 Jun; 3(6 Suppl 1):S139-47. PubMed ID: 21703572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation.
    Kobeissy FH; Sadasivan S; Oli MW; Robinson G; Larner SF; Zhang Z; Hayes RL; Wang KK
    Proteomics Clin Appl; 2008 Oct; 2(10-11):1467-83. PubMed ID: 21136795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A neuroproteomic and systems biology analysis of rat brain post intracerebral hemorrhagic stroke.
    Ren C; Guingab-Cagmat J; Kobeissy F; Zoltewicz S; Mondello S; Gao M; Hafeez A; Li N; Geng X; Larner SF; Anagli J; Hayes RL; Ji X; Ding Y
    Brain Res Bull; 2014 Mar; 102():46-56. PubMed ID: 24583080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics analysis of the hippocampus in a rat model of traumatic brain injury during the acute phase.
    Zheng F; Zhou YT; Feng DD; Li PF; Tang T; Luo JK; Wang Y
    Brain Behav; 2020 Feb; 10(2):e01520. PubMed ID: 31908160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Systems Biology in Brain Injury Biomarker Discovery: Neuroproteomics Application.
    Jaber Z; Aouad P; Al Medawar M; Bahmad H; Abou-Abbass H; Ghandour H; Mondello S; Kobeissy F
    Methods Mol Biol; 2016; 1462():157-74. PubMed ID: 27604718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a systems-based in situ multiplex biomarker screening approach for the assessment of immunopathology and neural tissue plasticity in male rats after traumatic brain injury.
    Bogoslovsky T; Bernstock JD; Bull G; Gouty S; Cox BM; Hallenbeck JM; Maric D
    J Neurosci Res; 2018 Apr; 96(4):487-500. PubMed ID: 28463430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-traumatic administration of the p53 inactivator pifithrin-α oxygen analogue reduces hippocampal neuronal loss and improves cognitive deficits after experimental traumatic brain injury.
    Yang LY; Greig NH; Huang YN; Hsieh TH; Tweedie D; Yu QS; Hoffer BJ; Luo Y; Kao YC; Wang JY
    Neurobiol Dis; 2016 Dec; 96():216-226. PubMed ID: 27553877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.
    Robinson S; Winer JL; Berkner J; Chan LA; Denson JL; Maxwell JR; Yang Y; Sillerud LO; Tasker RC; Meehan WP; Mannix R; Jantzie LL
    J Neurosurg Pediatr; 2016 Jun; 17(6):739-55. PubMed ID: 26894518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein Biomarkers and Neuroproteomics Characterization of Microvesicles/Exosomes from Human Cerebrospinal Fluid Following Traumatic Brain Injury.
    Manek R; Moghieb A; Yang Z; Kumar D; Kobessiy F; Sarkis GA; Raghavan V; Wang KKW
    Mol Neurobiol; 2018 Jul; 55(7):6112-6128. PubMed ID: 29188495
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.